Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
1
x
$
30.00
Información Societaria
1
x
$
0.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos
1
x
$
0.00
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
1
x
$
30.00
Guía para la dosificación y el monitoreo de psicotrópicos para niños y adolescentes
1
x
$
30.00
Agomelatine Monotherapy for Autism—A Case Report
1
x
$
30.00
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
1
x
$
30.00
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
1
x
$
30.00
Coping With Somatic Comorbidities: Striving for Complete Recovery
1
x
$
30.00
Treatment of Parental Depression and Reduced Risk in Offspring-Does It Have Anything to Do with Offspring Gender?
1
x
$
30.00
Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento
1
x
$
0.00
Escitalopram Induced SIADH in an Elderly Female: A Case Study
1
x
$
30.00
Trichotieromania and Alopecia Areata Triggered by Aripiprazole- Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity
1
x
$
30.00
A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness
1
x
$
30.00
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
1
x
$
30.00
Epidemiología psiquiátrica: Psiquiatría social versus epidemiología
1
x
$
0.00
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
1
x
$
30.00
View Cart
Checkout
Home
Ahmed Naguy
“Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
$
30.00
Add to cart
Details
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
$
30.00
Add to cart
Details
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
$
30.00
Add to cart
Details
Bereavement During a Course of TMS for MDD: A Case Report
$
30.00
Add to cart
Details
Psychopharmacology: The ‘Combo Pills’-Did it find its way into Practice?
$
30.00
Add to cart
Details
Borderline Personality Disorder and Self-Injurious Behaviours— Attention-Seeking or Attachment- Seeking? Psychopharmacological Considerations
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Psychopharmacology of Catatonia: A Tour D’horizon
$
30.00
Add to cart
Details
Valproate-Autism Labyrinth
$
30.00
Add to cart
Details
Psychopharmacotherapy of Pica- How Much Do We Know?
$
30.00
Add to cart
Details
Anismus-A Very Unusual Extrapyramidal Side Effect of Paliperidone Palmitate in an Adolescent with Schizo-Affective Disorder
$
30.00
Add to cart
Details
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
$
30.00
Add to cart
Details
Clozapine Prescripers—Dogmatic or Pragmatic?
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
β-Blockers for Autism—Help or Hindrance?
$
30.00
Add to cart
Details
Treatment-Resistant Juvenile Depression—A Quicksand?
$
30.00
Add to cart
Details
Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
$
30.00
Add to cart
Details
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD
$
30.00
Add to cart
Details
Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder—Modus Operandi!
$
30.00
Add to cart
Details
The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
$
30.00
Add to cart
Details
1
2
Next
Page load link
Go to Top
